• Anti–miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response 

      Dragomir, Mihnea P.; Fuentes-Mattei, Enrique; Winkle, Melanie; Okubo, Keishi; Bayraktar, Recep; Knutsen, Erik; Qdaisat, Aiham; Chen, Meng; Li, Yongfeng; Shimizu, Masayoshi; Pang, Lan; Liu, Kevin; Liu, Xiuping; Anfossi, Simone; Zhang, Huanyu; Koch, Ines; Tran, Anh M.; Mohapatra, Swati; Ton, Anh; Kaplan, Mecit; Anderson, Matthew W.; Rothfuss, Spencer J.; Silasi, Robert; Keshari, Ravi S.; Ferracin, Manuela; Ivan, Cristina; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Georgescu, Constantin; Banerjee, Pinaki P.; Basar, Rafet; Li, Ziyi; Horst, David; Vasilescu, Catalin; Bertilaccio, Maria Teresa S.; Rezvani, Katayoun; Lupu, Florea; Yeung, Sai-Ching; Calin, George A. (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-06-01)
      Sepsis remains a leading cause of death for humans and currently has no pathogenesis-specific therapy. Hampered progress is partly due to a lack of insight into deep mechanistic processes. In the past decade, deciphering the functions of small noncoding miRNAs in sepsis pathogenesis became a dynamic research topic. To screen for new miRNA targets for sepsis therapeutics, we used samples for miRNA ...